Dr. Stephen C Beck, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 4427 Hobbs Dr, La Canada Flintridge, CA 91011 Phone: 818-261-0599 Fax: 818-790-5279 |
Dr. Edward Nana Opoku Jr., D.O. General Practice Medicare: Medicare Enrolled Practice Location: 2222 Foothill Blvd # E122, La Canada Flintridge, CA 91011 Phone: 310-936-4782 |
News Archive
Ariel Pharmaceuticals, Inc., a private, specialty pharmaceutical company focused on the development and commercialization of products for acute central nervous system (CNS) diseases and trauma, announced today that it has in-licensed its lead product, AP-1531, for the treatment of acute migraine attacks, from the specialist healthcare company BTG International Ltd.
A research team including NIBIB-funded scientists has developed an improved MRI technique with the potential to provide more precise and effective treatment for prostate cancer. The imaging technique improves upon standard MRI to obtain clearer images of the extent of the tumor and its exact location. A sharper image can provide more accurate biopsies, enable better treatment planning, and help surgeons pinpoint the tumor while sparing surrounding healthy tissue.
Canada's health experts are among the very best in the world, but Canadians may be surprised to learn that when it comes to reading their pathology reports, it is imperative that they seek a second opinion.
Hendra virus is a bat-borne virus that has killed four of the seven humans who have been infected and caused the deaths more than 40 horses since it was discovered in 1994. Humans contract the disease from horses but there has been neither human-to-human transmission of the disease nor direct transmission from bats to humans report experts. The majority of outbreaks have occurred during June and October, however last year a horse in Tewantin contracted the virus in May.
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have shown that breast cancer cells that metastasize to the lung express a higher level of the protein peroxiredoxin 2 (PRDX2). The study suggests that the modulation of the levels of this protein could be a new therapeutic strategy to prevent lung metastases.
› Verified 1 days ago